BYFAVO 2.5 mg/mL
remimazolam besylate · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Acacia Pharma, Ltd.
Remimazolam Besylate (Byfavo) is an intravenous sedative medication used to provide sedation during medical procedures. It belongs to a class of sedative drugs and works quickly to help patients remain calm and comfortable during diagnostic or therapeutic procedures.
Key Facts
- Brand Name
- BYFAVO
- Generic Name
- remimazolam besylate
- NDC Code (Product)
71390-011- Manufacturer
- Acacia Pharma, Ltd.
- Strength
- 2.5 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA212295
- Marketing Start
- 10/06/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is BYFAVO used for?
Remimazolam Besylate (Byfavo) is an intravenous sedative medication used to provide sedation during medical procedures. It belongs to a class of sedative drugs and works quickly to help patients remain calm and comfortable during diagnostic or therapeutic procedures.
Is BYFAVO a controlled substance?
Yes, BYFAVO is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for BYFAVO?
The generic name for BYFAVO is remimazolam besylate. There are no other listed brand versions of remimazolam besylate.
What is the NDC code for BYFAVO 2.5 mg/mL?
The NDC (National Drug Code) for BYFAVO 2.5 mg/mL is 71390-011, listed by Acacia Pharma, Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)